期刊文献+

盐酸青藤碱-聚乳酸/羟基乙酸共聚物缓释微球制备工艺的研究 被引量:4

Study on the preparation of poly( lactic-co-glycolic acid) microspheres containing sinomenine hydrochloride
下载PDF
导出
摘要 目的制备盐酸青藤碱(SM)-PLGA缓释微球。方法以PLGA为骨架材料,采用油包油乳化-溶剂挥发法制备盐酸青藤碱-PLGA缓释微球,以粒径、载药量为评价指标经正交试验筛选最优工艺;应用显微镜、扫描电镜、差示扫描量热分析等手段对微球进行表征,用高效液相色谱法测定微球载药量。结果正交试验最优工艺条件:Span80的质量分数为1%、溶剂挥发时间为6 h、PLGA摩尔质量为20 000 g/mol、SM与PLGA质量比为1∶5、转速为700 r/min、PLGA质量浓度为80 mg/m L;按最优工艺制备所得微球圆整,平均粒径为7.90μm,载药量为4.54%。结论采用油包油乳化-溶剂挥发法制备盐酸青藤碱-聚乳酸/羟基乙酸共聚物微球有较高载药量,具有较大的应用前景。 Objective To prepare poly( lactic-co-glycolic acid)( PLGA) microspheres containing sinomenine hydrochloride( SM). Methods Microspheres were prepared from PLGA using an oil-in-oil( O / O) solvent evaporation method. An orthogonal test was designed to optimize the process with particle size and drug loading as indices. Microspheres were characterized with a microscope,scanning electron microscopy and differential scanning calorimetry analysis,and the drug loading was measured by HPLC. Results The optimum method was as follows: 1% Span80,6 hours of solvent evaporation,20 000 g / mol of PLGA molecular weight,1∶ 5 weight ratio of SM to PLGA,700 r / min emulsification speed and 80 mg / m L PLGA concentration. Microspheres were round with an average particle size of 7. 90 μm and 4. 54% drug loading. Conclusion The PLGA microspheres containing sinomenine hydrochloride prepared using this O /O solvent evaporation method had an advantage of higher drug loading and good application prospect.
出处 《广东药学院学报》 CAS 2015年第3期285-290,共6页 Academic Journal of Guangdong College of Pharmacy
基金 广东省教育厅科技计划项目(GCZX-A0807)
关键词 油包油乳化-溶剂挥发法 盐酸青藤碱 聚乳酸/羟基乙酸 oil-in-oil solvent evaporation method sinomenine hydrochloride poly(lactic-co-glycolic acid)
  • 相关文献

参考文献6

二级参考文献43

共引文献33

同被引文献37

  • 1符旭东,高永良,平其能.制备工艺对石杉碱甲微球体外释药机制的影响[J].药学学报,2006,41(7):589-594. 被引量:2
  • 2李乐,张彩玲,宋必卫.青藤碱的药理研究与临床应用[J].中药新药与临床药理,2006,17(4):310-313. 被引量:75
  • 3张丽锋,张淑秋,侯晓锋.盐酸青藤碱控释微丸的制备及含量测定[J].中国药物与临床,2006,6(10):748-750. 被引量:8
  • 4王襄平,梅兴国.乳酸/羟基乙酸共聚物的分子量及其单体组成比例对利培酮微球性质的影响[J].中国药房,2007,18(1):38-41. 被引量:13
  • 5Zolnik BS, Burgess DJ. Evaluation of in vivo-in vitro re- lease of dexamethasone from PLGA microspheres [ J ]. J Control Release ,2008,127 (2) : 137.
  • 6Makino K, Nakajima T, Shikamura M. et al. Efficient in- tracellular delivery of rifampicin to alveolar maerophages using rifampiein-loaded PLGA microspheres: effects of molecular weight and composition of PLGA on release of rifampiein [ J ]. Colloids Surf B Biointerfaees, 2004,36 (1) :35.
  • 7Du L, Cheng J, Chi Q. et al. Biodegradable PLGA micro- spheres as a sustained release system for a new luteinizing hormone-releasing hormone ( LHRH ) antagonist [J]. Chem Pharm Bu11,2006,54(9) :1259.
  • 8Xuan J, Lin Y, Huang J, et al. Exenatide-loaded PLGA mi- crospheres with improved glycemic control :In vitro bioactivi-ty and in vivo pharmacokinetic pro? les after subcutaneous administration to SD rats [ J ]. Peptides ,2013 ,46 :172.
  • 9Diab R, Brillault J, Bardy A, et al. Formulation and in vitro characterization of inhalable polyvinyl alcohol-free rif- ampicin-loaded PLGA microspheres prepared with sucrose palmitate as stabilizer:efficiency for ex vivo alveolar mac- rophage targeting [ J]. Int J Pharm,2012,436(1-2) :833.
  • 10Ravi S, Peh KK, Darwis Y, et al. Development and char- acterization of polymeric microspheres for controlled re- lease protein loaded drug delivery system [ J ]. Indian J Pharm Sei,2008,70 ( 3 ) :303.

引证文献4

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部